First Patient Treated with Phase 1 Trial Combo of Reolysin, Opdivo, and Kyprolis
News
A Phase 1 trial of the combination of Reolysin (pelareorep), Kyprolis (carfilzomib), and Opdivo (nivolumab) in relapsed multiple myeloma treated the first patient. The open-label, dose escalation study (NCT03605719) will ... Read more